
A review of the DAVIO 2 phase 2 trial results
Katherine Talcott, MD, of Cleveland Clinic in Cleveland, Ohio presented results of the phase 2 DAVIO 2 trial (NCT05381948) of EYP-1901 (vorolanib intravitreal insert; a/k/a DURAVYU) for wet age-related macular degeneration (AMD) at the 2025 …